Lifestyle program to prevent muscle loss in older adults with diabetes on semaglutide
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests whether a lifestyle program (diet and exercise) can help prevent muscle loss in people 65 and older with type 2 diabetes and obesity who are taking semaglutide. It may help you keep your strength and independence while losing weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older.
- You have type 2 diabetes.
- You are overweight or obese (BMI 27 or higher).
- You have not taken weight-loss drugs (including semaglutide) in the last 3 months.
- You are not currently following a strict diet or weight-loss program (more than 5% loss in 3 months).
- You can exercise safely (no major hearing/vision problems, no walking aid, no recent hospitalization, and no conditions that limit exercise).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different diets to see how they affect “arterial stiffness” (how hard the blood vessels are) in people with obesity who are starting semaglutide for weight management. It may help find a diet approach that improves heart and blood-vessel health while you use semaglutide.
This study tests if a weekly injection (semaglutide) combined with an exercise program can help reduce fat stored in the heart and muscles in people with type 2 diabetes. It may improve how well your body handles sugar and lowers your risk for heart problems.
This study tests whether taking HMB and vitamin D can help older adults with type 2 diabetes keep their muscle mass while they start taking semaglutide for weight loss. It may help prevent muscle loss during weight management.
This study tests whether a 12-week program of exercise and personalized nutrition counseling can help obese adults maintain muscle and bone while taking GLP-1 medications (drugs that help with weight loss). GLP-1 drugs can sometimes cause muscle loss, so this trial explores whether targeted exercise and nutrition can prevent that.
This study tests a new injectable medication (semaglutide) compared to the approved drug Wegovy® for weight loss in people with obesity. It may help you lose weight if you have struggled to keep weight off with diet alone.
This trial tests if adding a natural compound called 20E (20-hydroxyecdysone) to the weight-loss drug semaglutide can help people with obesity lose more weight and keep muscle. You would take both medications and follow a diet and exercise plan.
Hear when a new Type 2 Diabetes Mellitus in Obese trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.